EUVIMEDEUVIMED entdecken
Übersichtsarbeit

From acute intervention to chronic management: biopharmaceutical barriers and advanced formulation strategies for peroral metronomic chemotherapy

Yirivinti Hayagreeva Dinakar, Raghu Ganugula, Anil K Sood, M N V Ravi Kumar, Meenakshi Arora

Advanced Drug Delivery Reviews · 2027-01 · 240 · 115988

DOI: 10.1016/j.addr.2026.115988 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2027-01. Verfasst von Yirivinti Hayagreeva Dinakar und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Center for Convergent Bioscience and Medicine (CCBM), The University of Alabama, Tuscaloosa, AL, USA; Department of Translational Science and Med…. Die Arbeit nennt 203 Literaturangaben. Gefördert von: University of Alabama.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although cancer is a chronic disease, conventional oncology has largely relied on maximum tolerated dose (MTD) chemotherapy to achieve rapid tumor killing. However, the limited specificity of these agents frequently results in substantial systemic toxicity and necessitates prolonged treatment-free intervals that may permit tumor regrowth and therapeutic resistance. Metronomic chemotherapy (MET) has emerged as a promising alternative approach, characterized by continuous or intermittent administration of low-dose chemotherapeutic agents over extended periods (often incorporating scheduled drug-free breaks ranging from daily up to weekly). Rather than relying primarily on direct cytotoxicity, MET exerts anti-tumor effects through repeated anti-angiogenic activity, immune modulation, and alteration of tumor microenvironment (TME), while minimizing treatment-related toxicity. These properties make MET particularly attractive for long-term cancer management. Despite its clinical promise, broader implementation of MET remains constrained by challenges associated with drug delivery and administration. For chronic therapeutic regimens, the peroral route represents the most practical and patient-friendly option, offering improved adherence, reduced healthcare burden, and fewer hospital visits. However, many chemotherapeutic agents possess poor aqueous solubility, limited membrane permeability, and unfavorable pharmacokinetic properties, resulting in inadequate peroral bioavailability. In this review, we discuss the evolving role of MET in cancer treatment, compare available routes of administration, and examine the major biopharmaceutical barriers to effective peroral delivery. We further highlight emerging formulation strategies and advanced drug delivery systems designed to overcome these limitations. Collectively, these advances may facilitate the transition of cancer therapy from an episodic, high-intensity intervention toward a sustainable long-term disease management strategy.

Schlagwörter

Stichwörter der Autor:innen

AngiogenesisClinical trialsMetronomic chemotherapyPeroral drug deliveryPreclinical studies

Autor:innen und Institutionen

  • The Center for Convergent Bioscience and Medicine (CCBM), The University of Alabama, Tuscaloosa, AL, USA; Department of Translational Science and Medicine, College of Community Health Sciences, The University of Alabama…
  • Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer…

Förderung

  • University of Alabama

Zitieren

APA

Dinakar, Y. H., Ganugula, R., Sood, A. K., Kumar, M. N. V. R., & Arora, M. (2027). From acute intervention to chronic management: biopharmaceutical barriers and advanced formulation strategies for peroral metronomic chemotherapy. Advanced Drug Delivery Reviews, 240, 115988. https://doi.org/10.1016/j.addr.2026.115988

Vancouver

Dinakar YH, Ganugula R, Sood AK, Kumar MNVR, Arora M. From acute intervention to chronic management: biopharmaceutical barriers and advanced formulation strategies for peroral metronomic chemotherapy. Advanced Drug Delivery Reviews. 2027;240:115988. doi:10.1016/j.addr.2026.115988

BibTeX
@article{Dinakar2027,
  author = {Dinakar, Yirivinti Hayagreeva and Ganugula, Raghu and Sood, Anil K and Kumar, M N V Ravi and Arora, Meenakshi},
  title = {From acute intervention to chronic management: biopharmaceutical barriers and advanced formulation strategies for peroral metronomic chemotherapy},
  journal = {Advanced Drug Delivery Reviews},
  year = {2027},
  volume = {240},
  pages = {115988},
  doi = {10.1016/j.addr.2026.115988}
}
Kostenlos starten →